---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-009941"
form_type: "8-K"
ticker: "GTBP"
cik: "0000109657"
company_name: "GT Biopharma, Inc."
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T12:42:43.175698+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# GT Biopharma appoints two new directors; two resign; board reduced to four

## Summary
- Board increased from 4 to 6 on May 7; Hilary Kramer appointed as non-employee director.
- Bruce Wendel resigned from Board and all committees on May 7.
- Andrew Ritter appointed as non-employee director on May 8.
- Rajesh Shrotriya resigned from Board and all committees on May 12.
- Board reduced to 4 members; Kramer chairs Nominating Committee, Ritter chairs Compensation Committee.

## SEC filing metadata
- accession: 0001641172-25-009941
- form_type: 8-K
- ticker: GTBP
- cik: 0000109657
- company_name: GT Biopharma, Inc.
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/109657/000164117225009941/0001641172-25-009941-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/109657/000164117225009941/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-009941
- JSON: https://secwatch.observer/filing/0001641172-25-009941.json
- Plain text: https://secwatch.observer/filing/0001641172-25-009941.txt

## Key facts
- Executive change
  Hilary Kramer was appointed as Non-Employee Director at GT Biopharma, Inc..
  - Action: appointed
  - Role: Non-Employee Director
  source text: appointed Hilary Kramer as a non-employee director to fill the vacancy created by the increase in the size of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/109657/000164117225009941/0001641172-25-009941-index.htm
- Executive change
  Andrew Ritter was appointed as Non-Employee Director at GT Biopharma, Inc..
  - Action: appointed
  - Role: Non-Employee Director
  source text: appointed Andrew Ritter as a non-employee director to fill one of the vacancies on the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/109657/000164117225009941/0001641172-25-009941-index.htm
- Executive change
  Bruce Wendel resigned as Director at GT Biopharma, Inc..
  - Action: resigned
  - Role: Director
  source text: Bruce Wendel resigned as a member of the Board and all committees thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/109657/000164117225009941/0001641172-25-009941-index.htm
- Executive change
  Rajesh Shrotriya resigned as Director at GT Biopharma, Inc..
  - Action: resigned
  - Role: Director
  source text: Rajesh Shrotriya resigned as a member of the Board and all committees thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/109657/000164117225009941/0001641172-25-009941-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.